phosphorylcholine has been researched along with Atrophy in 1 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otoki, Y | 1 |
| Yu, D | 1 |
| Shen, Q | 1 |
| Sahlas, DJ | 1 |
| Ramirez, J | 1 |
| Gao, F | 1 |
| Masellis, M | 1 |
| Swartz, RH | 1 |
| Chan, PC | 1 |
| Pettersen, JA | 1 |
| Kato, S | 1 |
| Nakagawa, K | 1 |
| Black, SE | 1 |
| Swardfager, W | 1 |
| Taha, AY | 1 |
1 other study available for phosphorylcholine and Atrophy
| Article | Year |
|---|---|
Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer's Disease and Subcortical Cerebrovascular Disease.
Topics: Alzheimer Disease; Atrophy; Cerebrovascular Disorders; Humans; Lipidomics; Lysophospholipids; Magnet | 2023 |